Literature DB >> 32931189

Normothermia in Patients With Sepsis Who Present to Emergency Departments Is Associated With Low Compliance With Sepsis Bundles and Increased In-Hospital Mortality Rate.

Sunghoon Park1, Kyeongman Jeon2, Dong Kyu Oh3, Eun Young Choi4, Gil Myeong Seong5, Jeongwon Heo6, Youjin Chang7, Won Gun Kwack8, Byung Ju Kang9, Won-Il Choi10, Kyung Chan Kim11, So Young Park12, Yoon Mi Shin13, Heung Bum Lee14, So Hee Park15, Seok Chan Kim16, Sang Hyun Kwak17, Jae Hwa Cho18, Beongki Kim19, Chae-Man Lim3.   

Abstract

OBJECTIVES: To investigate the impact of normothermia on compliance with sepsis bundles and in-hospital mortality in patients with sepsis who present to emergency departments.
DESIGN: Retrospective multicenter observational study. PATIENTS: Nineteen university-affiliated hospitals of the Korean Sepsis Alliance participated in this study. Data were collected regarding patients who visited emergency departments for sepsis during the 1-month period. The patients were divided into three groups based on their body temperature at the time of triage in the emergency department (i.e., hypothermia [< 36°C] vs normothermia [36-38°C] vs hyperthermia [> 38°C]).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 64,021 patients who visited emergency departments, 689 with community-acquired sepsis were analyzed (182 hyperthermic, 420 normothermic, and 87 hypothermic patients). The rate of compliance with the total hour-1 bundle was lowest in the normothermia group (6.0% vs 9.3% in hyperthermia vs 13.8% in hypothermia group; p = 0.032), the rate for lactate measurement was lowest in the normothermia group (62.1% vs 73.1% vs 75.9%; p = 0.005), and the blood culture rate was significantly lower in the normothermia than in the hyperthermia group (p < 0.001). The in-hospital mortality rates in the hyperthermia, normothermia, and hypothermia groups were 8.5%, 20.6%, and 30.8%, respectively (p < 0.001), but there was no significant association between compliance with sepsis bundles and in-hospital mortality. However, in a multivariate analysis, compared with hyperthermia, normothermia was significantly associated with an increased in-hospital mortality (odds ratio, 2.472; 95% CI, 1.005-6.080). This association remained significant even after stratifying patients by median lactate level.
CONCLUSIONS: Normothermia at emergency department triage was significantly associated with an increased risk of in-hospital mortality and a lower rate of compliance with the sepsis bundle. Despite several limitations, our findings suggest a need for new strategies to improve sepsis outcomes in this group of patients.

Entities:  

Mesh:

Year:  2020        PMID: 32931189     DOI: 10.1097/CCM.0000000000004493

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  The Presentation, Pace, and Profile of Infection and Sepsis Patients Hospitalized Through the Emergency Department: An Exploratory Analysis.

Authors:  Vincent X Liu; Meghana Bhimarao; John D Greene; Raj N Manickam; Adriana Martinez; Alejandro Schuler; Fernando Barreda; Gabriel J Escobar
Journal:  Crit Care Explor       Date:  2021-02-24

2.  Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study.

Authors:  Yunjoo Im; Danbee Kang; Ryoung-Eun Ko; Yeon Joo Lee; Sung Yoon Lim; Sunghoon Park; Soo Jin Na; Chi Ryang Chung; Mi Hyeon Park; Dong Kyu Oh; Chae-Man Lim; Gee Young Suh
Journal:  Crit Care       Date:  2022-01-13       Impact factor: 9.097

3.  Cost-effectiveness of the TherMax blood warmer during continuous renal replacement therapy.

Authors:  Michael J Blackowicz; Max Bell; Jorge Echeverri; Kai Harenski; Marcus E Broman
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

4.  Cluster analysis integrating age and body temperature for mortality in patients with sepsis: a multicenter retrospective study.

Authors:  Moon Seong Baek; Jong Ho Kim; Young Suk Kwon
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.